Volume 24, Issue 3 pp. 425-435
Original article

Prophylaxis and management of acute radiation-induced skin toxicity: a survey of practice across Europe and the USA

A. O'Donovan BSc

Corresponding Author

A. O'Donovan BSc

Assistant Professor

Applied Radiation Therapy Trinity (ARTT), Trinity College Dublin, Dublin, Ireland

Correspondence address: Anita O'Donovan, Discipline of Radiation Therapy, School of Medicine, Trinity College Dublin, Dublin, Ireland (e-mail: [email protected]).Search for more papers by this author
M. Coleman BSc

M. Coleman BSc

Radiation Therapist

Applied Radiation Therapy Trinity (ARTT), Trinity College Dublin, Dublin, Ireland

Search for more papers by this author
R. Harris D Clin Res, MSc, PgD, PgCCE, DCR (T), Tech IOSH

R. Harris D Clin Res, MSc, PgD, PgCCE, DCR (T), Tech IOSH

Professional Officer for Research

The Society and College of Radiographers, London, UK

Search for more papers by this author
P. Herst PhD, MPhil MSc

P. Herst PhD, MPhil MSc

Senior Lecturer

Department of Radiation Therapy, University of Otago, Wellington, New Zealand

Search for more papers by this author
First published: 01 July 2014
Citations: 27
The authors declare no conflict of interest.

Abstract

Radiation-induced toxicity is a common adverse side effect of radiation therapy. Previous studies have demonstrated a lack of evidence to support common skincare advice for radiotherapy patients. The aim of the current study was to investigate the management of radiation-induced skin toxicity across Europe and the USA. Where previous surveys have focused on national practice or treatment of specific sites, the current study aimed to gain a broader representation of skincare practice. An anonymous online survey investigating various aspects of radiotherapy skincare management was distributed to departments across Europe and the USA (n = 181/737 responded i.e. 25%). The UK was excluded as a similar survey was carried out in 2011. The results highlight the lack of consistency in both the prevention and management of radiation-induced skin toxicity. Recommended products are often not based on evidence-based practice. Examples include the continued use of aqueous cream and gentian violet, as well as the recommendations on washing restrictions during treatment. To our knowledge, this is the most extensive survey to date on the current management of radiation-induced skin toxicity. This study highlights significant disparities between clinical practice and research-based evidence published in recent systematic reviews and guidelines. Ongoing large prospective randomised trials are urgently needed.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.